$0.54
Today
as of Aug 5, 16:52 ET
Last 30 days
Recent Press Releases & News
NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
NeuroSense to Participate in Roth-Hosted KOL Webinar on the Future of ALS Treatment: "A Quest to Outrun ALS"
NeuroSense Says Phase 2b Trial of PrimeC in Amyotrophic Lateral Sclerosis Meets Primary Endpoint
Overview
52-week range
$0.63
$2.60
0% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for NRSN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.